HCXY Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- 5.0%
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
49 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Hercules Capital, Inc.
Company profileHercules Capital, Inc. (HCXY) is a prominent publicly traded business development company that specializes in providing customized financing solutions predominantly to enterprises in the life sciences and technology sectors. With a strong emphasis on capital preservation and risk-adjusted returns, Hercules combines its extensive industry expertise and strategic partnerships to deliver both debt and equity investments that fuel innovation and growth. The company's adept investment strategy effectively identifies high-potential firms within competitive markets, positioning Hercules as an…
Classification
- Sector
- Financials
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NONE
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer